SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+3.6%
5Y CAGR+17.0%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+3.6%/yr
vs +18.3%/yr prior
5Y CAGR
+17.0%/yr
Recent deceleration
Acceleration
-14.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$691.36M+38.8%
2024$498.26M+805.8%
2023$-70.59M-111.3%
2022$622.20M-0.5%
2021$625.27M+98.0%
2020$315.74M-21.2%
2019$400.48M+26.1%
2018$317.50M-22.6%
2017$410.40M+0.4%
2016$408.92M-